2d6 slow metabolizer pain medication

Summary

People with slow metabolizers of CYP2D6 and CYP2C19 may experience difficulty in managing pain with commonly prescribed opiate medications such as codeine, tramadol, hydrocodone, and oxycodone. 1 Additionally, they may also have difficulty in managing pain with diazepam, carisoprodol, clopidogrel, proton pump inhibitors, and several antidepressants including amitriptyline, clomipramine, doxepin, imipramine, and trimipramine. 1 CYP2D6 enzymes also break down other medicines such as ondansetron and beta blockers. 2

According to


See more results on Neeva


Summaries from the best pages on the web

Summary Cytochrome P450 2D6, known as CYP2D6, enzymes break down several commonly used medicines. These include codeine, tramadol, and some other pain relievers; ondansetron ; some medicines to treat depression or other mental health disorder; and beta blockers (used for heart conditions and high blood pressure).
Cytochrome P450 2D6 (CYP2D6) and Medicines - Together by St. Jude™
favIcon
stjude.org

CYP2D6 metabolizer phenotype (ultra-rapid [UM], normal metabolizer [NM], intermediate [IM], or poor [PM]), the latter two of which may cause inefficacy of codeine, tramadol, and standard-dose hydrocodone, was determined for…
Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among ... - PubMed
favIcon
nih.gov

For instance, CYP-2D6 is completely responsible for some drugs’ metabolism. It appears completely re-sponsible for the metabolism of the antihypertensive/B-blocker, metoprolol (Lopressor®/Toprol®), while the antihypertensive/B blocker, propranolol (In-deral®) is metabolized…
Non-responsive Pain Patients with CYP-2D6 Defect
favIcon
practicalpainmanagement.com

CYP2D6 -guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers : a pragmatic clinical trial CYP2D6 -guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers : a pragmatic…
CYP2D6-guided opioid therapy improves pain control in CYP2D6 ... - PubMed
favIcon
nih.gov

Introduction: Cytochrome P450 enzymes are essential for the metabolism of many medications. Genetic variability (polymorphism) in these enzymes may influence a patient's response to commonly prescribed drug classes. CYP2D6 and…
"Rare Case of CYP2D6 and CYP2C19 Poor Metabolizer: A Pain Management Di ...
favIcon
henryford.com

Codeine is metabolized by CYP2D6 to its active metabolite, morphine. Clinical studies have shown that CYP2D6 poor metabolizers have poor analgesic response as a result of the reduced...
Genetic Factors in Drug Metabolism | AAFP
favIcon
aafp.org

The second class includes antiarrhythmic medications such as flecainide, lidocaine, mexiletine, propafenone, and quinidine. Lastly, the other remaining medication substrates that are worth mentioning include cinacalcet, dextromethorphan, dolasetron, ondansetron, ritonavir,…
What Medications are Likely to be Influenced by the Genetic ...
favIcon
ebmconsult.com

Medications : The CYP2D6 enzyme metabolizes (breaks down) about 25% of pharmaceutical drugs , including SSRIs, opioids, tamoxifen, dextromethorphan, and beta-blockers. Which drugs are metabolized by CYP2D6 ? Here is a partial list…
CYP2D6 gene and medication reactions - Genetic Lifehacks
favIcon
geneticlifehacks.com